Avobenzone/Zinc/Phenylbenzimidazole Sunscreen Efficacy Data Needed - FDA
This article was originally published in The Tan Sheet
Executive Summary
Additional efficacy data are needed before FDA can approve the use of avobenzone with zinc oxide and phenylbenzimidazole sulfonic acid in OTC sunscreens, the agency tells Procter & Gamble in a Sept. 15 letter.
You may also be interested in...
P&G Avobenzone Combo Data Demonstrate Broad Spectrum Protection - FDA
The combinations of avobenzone and either zinc oxide or phenylbenzimidazole sulfonic acid (PBSA) are safe and effective for use in sunscreens "when used in the concentrations established for each ingredient" in the sunscreen final monograph, FDA tells Procter & Gamble in a Nov. 2 letter.
P&G Avobenzone Combo Data Demonstrate Broad Spectrum Protection - FDA
The combinations of avobenzone and either zinc oxide or phenylbenzimidazole sulfonic acid (PBSA) are safe and effective for use in sunscreens "when used in the concentrations established for each ingredient" in the sunscreen final monograph, FDA tells Procter & Gamble in a Nov. 2 letter.
P&G Avobenzone Combo Data Demonstrate Broad Spectrum Protection - FDA
The combinations of avobenzone and either zinc oxide or phenylbenzimidazole sulfonic acid (PBSA) are safe and effective for use in sunscreens "when used in the concentrations established for each ingredient" in the sunscreen final monograph, FDA tells Procter & Gamble in a Nov. 2 letter.